Genetic and pathologic evolution of early secondary gliosarcoma.

Area of Science:

• Neuro-oncology
• Cancer Genomics
• Pathology

Background:

• Gliosarcoma, a rare glioblastoma subtype, presents with both glial and mesenchymal elements.
• True secondary gliosarcomas arising from lower-grade precursors without prior radiation are exceptionally uncommon.
• Understanding the genomic underpinnings of gliosarcoma progression is crucial for developing targeted therapies.

Observation:

• A 61-year-old male with a fibrillary astrocytoma (WHO grade II) developed gliosarcoma upon recurrence.
• The recurrent tumor exhibited an infiltrating glial component and a distinct sarcomatous component surrounding intratumoral vessels.
• IDH1(R132H) mutation was present in all tumor components, indicating a common cellular origin.

Findings:

• Comparative genomic hybridization revealed shared copy number alterations between the precursor glioma and the recurrent gliosarcoma.
• Specific genetic alterations, including homozygous deletion of CDKN2A, were identified in the recurrent tumor.
• Additional unique copy number alterations were observed exclusively in the sarcomatous component, suggesting distinct evolutionary pathways.

Implications:

• This case highlights the complex genomic landscape of gliosarcoma development from lower-grade precursors.
• The identification of specific genetic alterations in the sarcomatous component may offer novel therapeutic targets.
• Further research into the genetic drivers of gliosarcoma progression is warranted to improve patient outcomes.